Work

Profiling of 3,634 cholangiocarcinomas (CCA) to identify genomic alterations (GA), tumor mutational burden (TMB), and genomic loss of heterozygosity (gLOH).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.4087

Authors: Milind M. Javle, Karthikeyan Murugesan, Rachna T. Shroff, Mitesh J. Borad, Reham Abdel-Wahab, Alexa Betzig Schrock, Jon Chung, Lipika Goyal, Garrett M. Frampton, Robin Kate Kelley, Vincent A. Miller, Jeffrey S. Ross, Tanios S. Bekaii-Saab, Siraj Mahamed Ali, Lee A. Albacker

Institutions: The University of Texas MD Anderson Cancer Center, Foundation Medicine (United States), Mayo Clinic, Mayo Clinic in Arizona, Assiut University Hospitals, Assiut University, Massachusetts General Hospital, University of California, San Francisco, SUNY Upstate Medical University, Mayo Clinic Hospital

Language: English

Topic: Cholangiocarcinoma and Gallbladder Cancer Studies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947232059

Cites:

Cited by: 59

Related to: 10